ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

NMRD Nemaura Medical Inc

0.1053
0.00 (0.00%)
26 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Nemaura Medical Inc NMRD 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 0.1053 09:00:00
개장가 저가 고가 종가 전일 종가
0.1053 0.1053
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
20/04/202405:05EDGAR2Form PRE 14C - Other preliminary information statements
11/04/202405:16EDGAR2Form 8-K - Current report
27/02/202406:05EDGAR2Form 8-K - Current report
23/01/202406:15GLOBEMaxim Group LLC to Host the 2024 Healthcare IT Virtual..
18/01/202407:17EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/01/202407:15EDGAR2Form DEF 14A - Other definitive proxy statements
10/01/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202407:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/01/202406:30EDGAR2Form 8-K - Current report
03/01/202421:00EDGAR2Form 8-K - Current report
03/01/202421:00GLOBEImportant Update on Listing Status and Strategic Direction
13/12/202322:00EDGAR2Form 8-K - Current report
13/12/202322:00GLOBENemaura Medical Inc. Receives Positive Nasdaq Listing..
08/12/202300:46EDGAR2Form PRE 14A - Other preliminary proxy statements
21/11/202322:38EDGAR2Form 8-K - Current report
21/11/202322:30GLOBENemaura Medical Inc. Secures $10 Million Non-Dilutive Credit..
14/11/202322:00GLOBENemaura Launches Direct to Consumer Offering of Metabolic..
14/11/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:15EDGAR2Form 8-K - Current report
14/11/202306:14GLOBENemaura Medical Reports Fiscal Second Quarter 2024 Results..
13/10/202305:05EDGAR2Form 8-K - Current report
07/10/202305:10EDGAR2Form 8-K - Current report
26/09/202322:50GLOBENemaura Medical Announces Appointment of Mr Nikolai Rozanov..
23/09/202304:05GLOBEMaxim Group LLC to Host the Virtual Tech Conference Series:..
18/09/202322:15GLOBENemaura Medical to Present at the Maxim Group Emerging..
14/09/202321:00EDGAR2Form 8-K - Current report
14/09/202321:00GLOBENemaura Medical Provides Update on Nasdaq Compliance Status..
13/09/202321:03EDGAR2Form 8-K - Current report
13/09/202321:00GLOBENemaura Medical Announces Interim Results from its..
12/09/202322:26GLOBENemaura Medical Announces Participation at HLTH 2023, Las..
12/09/202305:41EDGAR2Form 424B8 - Prospectus filed pursuant to Rule 424(b)(8)
11/09/202322:00EDGAR2Form 8-K - Current report
09/09/202305:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/09/202305:15EDGAR2Form DEF 14A - Other definitive proxy statements
17/08/202321:30EDGAR2Form 8-K - Current report
17/08/202321:30GLOBENemaura Medical Announces SFDA Approval of sugarBEAT®
14/08/202321:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/08/202321:30EDGAR2Form 8-K - Current report
14/08/202321:30GLOBENemaura Medical Reports Fiscal First Quarter 2024 Results..
12/08/202306:07EDGAR2Form 8-K - Current report
12/08/202305:05GLOBENemaura Medical Secures $6.5m in Non-Dilutive Funding
11/08/202305:05EDGAR2Form PRE 14A - Other preliminary proxy statements
04/08/202305:08EDGAR2Form POS AM - Post-Effective amendments for registration..
17/07/202322:30EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
14/07/202322:25GLOBENemaura Medical Reports Financial Results and Provides..
14/07/202322:18EDGAR2Form 8-K - Current report
14/07/202305:31EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/06/202319:05EDGAR2Form NT 10-K - Notification of inability to timely file Form..
27/06/202322:00GLOBENemaura Medical Scales-Up Pilot Expansion of proBEAT™; 56..
22/06/202321:00GLOBENemaura Medical to Participate at the Collision Conference..

최근 히스토리

Delayed Upgrade Clock